Update on cardio-oncology: Novel cancer therapeutics and associated cardiotoxicitie

被引：43

作者：

Guha, Avirup ^{[1
]}

Armanious, Merna ^{[2
,3
]}

Fradley, Michael G. ^{[2
,3
]}

机构：

[1] Ohio State Univ, Div Cardiovasc Med, Columbus, OH 43210 USA

[2] Univ S Florida, Div Cardiovasc Med, Cardiooncol Program, 2 Tampa Gen Circle, Tampa, FL 33606 USA

[3] H Lee Moffitt Canc Ctr & Res Inst, Cardiooncol Program, 12902 USF Magnolia Dr, Tampa, FL 33612 USA

来源：

TRENDS IN CARDIOVASCULAR MEDICINE | 2019年 / 29卷 / 01期

关键词：

Cardio-oncology; Cardiotoxicity; Tyrosine kinase inhibitors; Proteasome inhibitors; CELL LUNG-CANCER; TYROSINE KINASE INHIBITOR; CHRONIC MYELOID-LEUKEMIA; METASTATIC BREAST-CANCER; HISTONE DEACETYLASE INHIBITORS; CHRONIC LYMPHOCYTIC-LEUKEMIA; PLATINUM-BASED CHEMOTHERAPY; ARTERIAL OCCLUSIVE DISEASE; DABRAFENIB PLUS TRAMETINIB; MISMATCH REPAIR-DEFICIENT;

D O I：

10.1016/j.tcm.2018.06.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

There have been significant advances in the field of oncology leading to improved survival as a result of novel targeted and immunotherapies. Despite these improved outcomes, there is increased recognition of cardiotoxicities associated with these therapies that can lead to significant morbidity and mortality. As such, the field of cardio-oncology has seen significant growth over the last several years. In this review, we discuss recent advances in the field of cardio-oncology and provide a detailed discussion of the cardiovascular complications associated with novel cancer therapeutics including tyrosine kinase inhibitors, proteasome inhibitors, histone deacetylase inhibitors, CDK4/6 inhibitors and immunotherapies. (C) 2018 Elsevier Inc. All rights reserved.

引用

页码：29 / 39

页数：11

共 50 条

[41] Cardiovascular Imaging in Cardio-Oncology The Role of Echocardiography and Cardiac MRI in Modern Cardio-Oncology
Gambril, John Alan
Chum, Aaron
Goyal, Akash
Ruz, Patrick
Mikrut, Katarzyna
Simonetti, Orlando
Dholiya, Hardeep
Patel, Brijesh
Addison, Daniel
HEART FAILURE CLINICS, 2022, 18 (03) : 455 - 478
[42] Update to the ESC guideline on cardio-oncology New approaches to managing cardiovascular risks in cancer patients
Romann, Sebastian Welf
Frey, Norbert
Lehmann, Lorenz
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (12) : 719 - 723
[43] Digital Therapeutics-Based Cardio-Oncology Rehabilitation for Lung Cancer Survivors: Randomized Controlled Trial
Li, Guangqi
Zhou, Xueyan
Deng, Junyue
Wang, Jiao
Ai, Ping
Zeng, Jingyuan
Ma, Xuelei
Liao, Hu
JMIR MHEALTH AND UHEALTH, 2025, 13
[44] Precision Cardio-oncology: Update on Omics-Based Diagnostic Methods
Kuang, Ziyu
Kong, Miao
Yan, Ningzhe
Ma, Xinyi
Wu, Min
Li, Jie
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (05) : 679 - 701
[45] Update Kardioonkologie: Anthrazyklin-ChemotherapieUpdate on cardio-oncology: anthracycline chemotherapy
Lars Michel
Tienush Rassaf
Die Kardiologie, 2023, 17 : 449 - 460
[46] Cardiac computed tomography in cardio-oncology: an update on recent clinical applications
Rosmini, Stefania
Aggarwal, Ankita
Chen, Daniel H.
Conibear, John
Davies, Ceri L.
Dey, Amit Kumar
Edwards, Paula
Guha, Avirup
Ghosh, Arjun K.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2021, 22 (04) : 397 - 405
[47] The role of ferroptosis in cardio-oncology
Hou, Kai
Liu, Lin
Fang, Zhi-Hui
Zong, Wei-Xing
Sun, Daqiang
Guo, Zhigang
Cao, Lu
ARCHIVES OF TOXICOLOGY, 2024, 98 (03) : 709 - 734
[48] Argentinean Cardio-Oncology Survey
Marquez, Julia S.
REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2023, 52 (02): : 68 - 71
[49] Fibroblast activation in cardio-oncology
Loganath, K.
Craig, N.
Joshi, S.
Barton, A.
Gibson, K.
Wall, L.
Waight, C.
Oikinomidou, O.
Hall, P.
Newby, D.
Henriksen, P.
Dweck, M.
EUROPEAN HEART JOURNAL, 2024, 45
[50] Evolving field of cardio-oncology
Li, Guo
Zhang, Lijun
Liu, Meiyan
CANCER PATHOGENESIS AND THERAPY, 2023, 1 (02): : 141 - 145

← 1 2 3 4 5 →